14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 XERS stock ended at $1.90. This is 0.265% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 4.51% from a day low at $1.89 to a day high of $1.97.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Xeris Pharmaceuticals Inc prices

Date Open High Low Close Volume
May 06, 2024 $1.95 $1.97 $1.89 $1.90 1 356 483
May 03, 2024 $1.90 $1.93 $1.84 $1.89 1 118 354
May 02, 2024 $1.79 $1.88 $1.75 $1.86 1 177 474
May 01, 2024 $1.74 $1.83 $1.73 $1.75 1 284 186
Apr 30, 2024 $1.74 $1.80 $1.72 $1.75 794 724
Apr 29, 2024 $1.73 $1.78 $1.71 $1.75 911 344
Apr 26, 2024 $1.71 $1.75 $1.69 $1.75 851 125
Apr 25, 2024 $1.76 $1.76 $1.70 $1.70 863 165
Apr 24, 2024 $1.78 $1.80 $1.74 $1.76 694 220
Apr 23, 2024 $1.80 $1.90 $1.78 $1.78 1 339 837
Apr 22, 2024 $1.72 $1.84 $1.70 $1.78 1 307 819
Apr 19, 2024 $1.76 $1.78 $1.69 $1.74 1 999 321
Apr 18, 2024 $1.80 $1.80 $1.73 $1.76 1 067 012
Apr 17, 2024 $1.80 $1.83 $1.75 $1.78 1 496 806
Apr 16, 2024 $1.85 $1.86 $1.77 $1.80 1 752 805
Apr 15, 2024 $1.90 $1.96 $1.83 $1.85 1 769 765
Apr 12, 2024 $2.02 $2.05 $1.87 $1.91 2 044 531
Apr 11, 2024 $1.97 $2.04 $1.96 $2.03 1 477 496
Apr 10, 2024 $1.99 $2.01 $1.93 $1.98 1 577 174
Apr 09, 2024 $2.01 $2.07 $2.01 $2.02 860 935
Apr 08, 2024 $2.05 $2.06 $1.99 $2.02 914 165
Apr 05, 2024 $2.04 $2.08 $2.01 $2.04 1 029 808
Apr 04, 2024 $2.11 $2.11 $2.02 $2.05 1 597 241
Apr 03, 2024 $2.06 $2.11 $2.05 $2.08 1 226 200
Apr 02, 2024 $2.11 $2.12 $2.06 $2.09 932 753
Click to get the best stock tips daily for free!

About Xeris Pharmaceuticals Inc

Xeris Pharmaceuticals Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhi... XERS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT